Article Details

Magrolimab Shows Promise in MDS and AML - Targeted Oncology

Retrieved on: 2022-10-04 18:06:53

Tags for this article:

Click the tags to see associated articles and topics

Magrolimab Shows Promise in MDS and AML - Targeted Oncology. View article details on hiswai:

Excerpt

Naval G. Daver, MD, discusses the latest research on magrolimab, a CD47 monoclonal antibody, for patients with acute myeloid leukemia and ...

Article found on: www.targetedonc.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up